Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Zambon

Showing results (111-120 of 261) with videos related to

Pageof 27
Sort By:
Emerging Infectious Diseases|August 23, 2014
Enhanced MERS coronavirus surveillance of travelers from the Middle East to EnglandHelen Lucy Thomas, Hongxin Zhao, Helen K Green, et al.
The Journal of Antimicrobial Chemotherapy|June 14, 2013
Virological self-sampling to monitor influenza antiviral susceptibility in a community cohortAngie Lackenby, Alex J Elliot, Cassandra Powers, et al.
Vaccine|April 17, 2009
DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trialSuzanne Jones, Kirsten Evans, Hilary McElwaine-Johnn, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 7, 2019
Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017Mark Reacher, Ben Warne, Lucy Reeve, et al.
Health Science Reports|December 10, 2021
Comparison of SARS-CoV-2 neutralizing antibody testing of convalescent plasma donations in the Netherlands and England: A pilot studyHeli Harvala, Robin Gopal, Monika Patel, et al.
JMIR Research Protocols|August 12, 2022
Assessing the Clinical and Socioeconomic Burden of Respiratory Syncytial Virus in Children Aged Under 5 Years in Primary Care: Protocol for a Prospective Cohort Study in England and Report on the Adaptations of the Study to the COVID-19 PandemicUy Hoang, Elizabeth Button, Miguel Armstrong, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their useArnold S Monto, Jennifer L McKimm-Breschkin, Catherine Macken, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 24, 2020
Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020Heli Harvala, Jennifer Mehew, Matthew L Robb, et al.
Plos One|August 7, 2025
Diagnostic accuracy evaluation of a point-of-care antigen test for SARS-CoV-2 and influenza in UK primary care (RAPTOR-C19)Thomas R Fanshawe, Sharon Tonner, Philip J Turner, et al.
Plos One|February 2, 2013
Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccineRichard Puleston, George Bugg, Katja Hoschler, et al.
Pageof 27

Showing results (111-120 of 261) with videos related to

Sort By:
Pageof 27
Emerging Infectious Diseases|August 23, 2014
Enhanced MERS coronavirus surveillance of travelers from the Middle East to EnglandHelen Lucy Thomas, Hongxin Zhao, Helen K Green, et al.
The Journal of Antimicrobial Chemotherapy|June 14, 2013
Virological self-sampling to monitor influenza antiviral susceptibility in a community cohortAngie Lackenby, Alex J Elliot, Cassandra Powers, et al.
Vaccine|April 17, 2009
DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trialSuzanne Jones, Kirsten Evans, Hilary McElwaine-Johnn, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 7, 2019
Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017Mark Reacher, Ben Warne, Lucy Reeve, et al.
Health Science Reports|December 10, 2021
Comparison of SARS-CoV-2 neutralizing antibody testing of convalescent plasma donations in the Netherlands and England: A pilot studyHeli Harvala, Robin Gopal, Monika Patel, et al.
JMIR Research Protocols|August 12, 2022
Assessing the Clinical and Socioeconomic Burden of Respiratory Syncytial Virus in Children Aged Under 5 Years in Primary Care: Protocol for a Prospective Cohort Study in England and Report on the Adaptations of the Study to the COVID-19 PandemicUy Hoang, Elizabeth Button, Miguel Armstrong, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their useArnold S Monto, Jennifer L McKimm-Breschkin, Catherine Macken, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 24, 2020
Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020Heli Harvala, Jennifer Mehew, Matthew L Robb, et al.
Plos One|August 7, 2025
Diagnostic accuracy evaluation of a point-of-care antigen test for SARS-CoV-2 and influenza in UK primary care (RAPTOR-C19)Thomas R Fanshawe, Sharon Tonner, Philip J Turner, et al.
Plos One|February 2, 2013
Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccineRichard Puleston, George Bugg, Katja Hoschler, et al.
Pageof 27